Cargando…
Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study
We formulated a traditional Chinese medicine (TCM) prescription, Hanshiyi Formula (HSYF), which was approved and promoted by the Wuhan Municipal Health Commission for treating mild and moderate coronavirus disease 2019 (COVID-19). We aimed to evaluate the effect of HSYF on the progression to severe...
Autores principales: | Tian, Jiaxing, Yan, Shiyan, Wang, Han, Zhang, Ying, Zheng, Yujiao, Wu, Haoran, Li, Xiuyang, Gao, Zezheng, Ai, Yanke, Gou, Xiaowen, Zhang, Lei, He, Liyun, Lian, Fengmei, Liu, Baoyan, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416080/ https://www.ncbi.nlm.nih.gov/pubmed/32791263 http://dx.doi.org/10.1016/j.phrs.2020.105127 |
Ejemplares similares
-
Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome
por: Tian, Jiaxing, et al.
Publicado: (2021) -
Effect of heat-clearing and detoxifying Chinese medicines combined with conventional therapy on mild hand, foot, and mouth disease with fever: An individual patient data meta-analysis
por: Yan, Shiyan, et al.
Publicado: (2020) -
Clinical Features for Mild Hand, Foot and Mouth Disease in China
por: Liu, Baoyan, et al.
Publicado: (2015) -
Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021
por: Zhang, Ying, et al.
Publicado: (2022) -
Understanding COVID-19 in Wuhan From the Perspective of Cold-Dampness: Clinical Evidences and Mechanisms
por: Zheng, Yujiao, et al.
Publicado: (2021)